Chicago, Jan. 27, 2026 (GLOBE NEWSWIRE) -- The global viral vectors & plasmid DNA manufacturing market was valued at 4.21 billion in 2024 and is expected to reach US$ 20.30 billion by 2033, growing at ...

DUBLIN--(BUSINESS WIRE)--The "Viral Vectors & Plasmid DNA Manufacturing Market Report 2024-2034" report has been added to ResearchAndMarkets.com's offering. Overall world revenue for the viral vectors ...

Increase in funding for R&D activities, surge in awareness regarding gene therapy, and rise in prevalence of cancer, viral infections, and genetic disorders drive the growth of the global viral ...

New York, July 16, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Viral Vectors & Plasmid DNA Global Market Report 2020-30: Covid 19 ...

The global viral vectors & plasmid DNA manufacturing market size is expanding over US$ 1.3 billion by 2027, according to new study by Precedence Research. OTTAWA, Sept. 30, 2020 (GLOBE NEWSWIRE) -- ...

Cell and gene therapies are redefining the treatments of rare diseases and cancers. Two CAR-T therapies, for instance, rapidly achieved FDA approval in the US and have emerged recently as the new ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Viral Vectors and Plasmid DNA Manufacturing Market, 2016-2026" report to their offering. The "Viral Vectors and Plasmid ...

Astute Analytica released an extensive market assessment report titled “Global Viral vectors & plasmid DNA manufacturing market: Trends, Industry Competition Analysis, Revenue, and Forecast to 2033.” ...

This study is led by Prof. Qunxin She (Shandong University) and Dr. Guanhua Yuan (Shandong University). The research group has constructed versatile genetic tools for Saccharolobus islandicus REY15A, ...

(MENAFN- GlobeNewsWire - Nasdaq) The surge is fueled by a rapidly expanding gene and cell therapy pipeline, with over 4,000 therapies in development and more than 2,000 active clinical trials ...